ISIN | LU2591956839 |
---|---|
Valorennummer | 125205293 |
Bloomberg Global ID | UBHELUX LX |
Fondsname | UBS (Lux) Equity SICAV - Healthy Living (USD) U-X-acc |
Fondsanbieter |
UBS Asset Management Switzerland AG, Zurich
Basel, Schweiz Telefon: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fondsanbieter | UBS Asset Management Switzerland AG, Zurich |
Vertreter in der Schweiz |
UBS Fund Management (Switzerland) AG Basel Telefon: +41 61 288 49 10 |
Distributor(en) | |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | Equity Health Care |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
Investment-Strategie *** | UBS Asset Management categorises this sub-fund as a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least 80% of its assets in equities and other equity interests of companies in developed and emerging markets worldwide that have exposure to sustainable themes which the Portfolio Manager considers to be critical to the trend of healthy living and disease prevention. Those include but are not limited to, healthy lifestyle, healthy nutrition, consumerization of health, disease prevention, mental well-being and longevity. Lifespan increased significantly over the past century, yet the time spent in a healthy state (i.e. health span) still lags behind. |
Besonderheiten |
Aktueller Preis * | 11'191.57 USD | 14.11.2024 |
---|---|---|
Vorheriger Preis * | 11'326.71 USD | 13.11.2024 |
52 Wochen Hoch * | 11'776.88 USD | 27.09.2024 |
52 Wochen Tief * | 9'420.77 USD | 16.11.2023 |
NAV * | 11'191.57 USD | 14.11.2024 |
Ausgabepreis * | 11'191.57 USD | 14.11.2024 |
Rücknahmepreis * | 11'191.57 USD | 14.11.2024 |
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 4'628'022 | |
Anteilsklassevermögen *** | 4'300'669 | |
Trading Information SIX |
YTD-Performance | +9.04% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
---|---|---|
YTD-Performance (in CHF) | +15.35% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
1 Monat | -3.95% |
14.10.2024 - 14.11.2024
14.10.2024 14.11.2024 |
3 Monate | +0.50% |
14.08.2024 - 14.11.2024
14.08.2024 14.11.2024 |
6 Monate | +0.63% |
14.05.2024 - 14.11.2024
14.05.2024 14.11.2024 |
1 Jahr | +18.40% |
14.11.2023 - 14.11.2024
14.11.2023 14.11.2024 |
2 Jahre | +12.37% |
06.07.2023 - 14.11.2024
06.07.2023 14.11.2024 |
3 Jahre | - | - |
5 Jahre | - | - |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Koninklijke Philips NV | 6.92% | |
---|---|---|
Danone SA | 6.19% | |
Eli Lilly and Co | 5.49% | |
Haleon PLC | 5.16% | |
Mowi ASA | 4.01% | |
Novo Nordisk AS Class B | 3.90% | |
Alcon Inc | 3.86% | |
Shimano Inc | 3.51% | |
Novonesis (Novozymes) B Class B | 3.19% | |
Cava Group Inc | 3.01% | |
Letzte Daten-Aktualisierung | 30.09.2024 |
TER | |
---|---|
Datum TER | |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | |
SRRI ***
|
|
Datum SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** |
Sustainable Investment |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |